Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

por Janssens, Ann, Berneman, Zwi N., Offner, Fritz, Snauwaert, Sylvia, Mineur, Philippe, Vanstraelen, Gaetan, Meers, Stef, Spoormans, Isabelle, Bron, Dominique, Vande Broek, Isabelle, Van Bogaert, Charlotte, De Beleyr, Birgit, Smet, Ann, Nielsen, Lasse, Wapenaar, Robert, André, Marc
Publicado 2022

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry

por Devos, Timothy, Havelange, Violaine, Theunissen, Koen, Meers, Stef, Benghiat, Fleur Samantha, Gadisseur, Alain, Vanstraelen, Gaëtan, Vellemans, Hélène, Bailly, Benjamin, Granacher, Nikki, Lewalle, Philippe, De Becker, Ann, Van Eygen, Koen, Janssen, Mia, Triffet, Agnes, Vrelust, Inge, Deeren, Dries, Mazure, Dominiek, Bekaert, Julie, Beck, Michael, Selleslag, Dominik
Publicado 2021